OFIX
Orthofix Medical Inc. (OFIX) PESTLE Analysis Analysis (2026)
Political
No major political or regulatory catalysts are evident from the current data.
Economic
Valuation remains inexpensive at 0.50x sales and 0.99x book, but profitability is still negative with TTM net margin of -7.4%.
Liquidity is solid with a current ratio of 2.84, while leverage is manageable at 0.55x debt-to-equity and 1.22x net debt-to-EBITDA.
Cash generation remains weak, with negative free cash flow yield of -6.5% and negative free cash flow to firm.
Social
No material social or consumer-demand developments are evident in the current data.
Technological
R&D intensity is modest at 7.4% of revenue, with no new product or technology announcements in the latest news.
Legal
No material legal or litigation developments are evident in the current data.
Environmental
No material environmental or sustainability developments are evident in the current data.
Overall Score
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Orthofix Medical Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.